Loading...
Biocon Pharma Limited — Tacrolimus Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #7 for Tacrolimus · $1.1M export value · DGFT Verified
Biocon Pharma Limited is the #7 Indian exporter of Tacrolimus with $1.1M in export value and 22 verified shipments. Biocon Pharma Limited holds a 0.5% market share in Tacrolimus exports across 2 countries. The company exports 8 pharmaceutical products worth $112.4M across 4 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| MEXICO | $546.6K | 11 | 49.9% |
| UNITED STATES | $348.2K | 7 | 31.8% |
| UNITED STATES OF AMERICA | $200.0K | 4 | 18.3% |
Biocon Pharma Limited exports Tacrolimus to 3 countries. The largest destination is MEXICO accounting for 49.9% of Biocon Pharma Limited's Tacrolimus shipments, followed by UNITED STATES (31.8%) and UNITED STATES OF AMERICA (18.3%). These destinations reflect Biocon Pharma Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BIOCON PHARMA INC | UNITED STATES | $348.2K | 7 |
| XXBORXXORIXX VAXXUISXX S XX DEXX V | MEXICO | $250.0K | 5 |
| XXOCOXXPHAXXA IXX | UNITED STATES OF AMERICA | $200.0K | 4 |
| LABORATORIOS VANQUISH S A DE C V | MEXICO | $150.0K | 3 |
| XXBORXXORIXX VAXXUISXX S XXDE XXV | MEXICO | $146.6K | 3 |
Biocon Pharma Limited supplies Tacrolimus to 5 buyers globally. The largest buyer is BIOCON PHARMA INC (UNITED STATES), followed by XXBORXXORIXX VAXXUISXX S XX DEXX V (MEXICO) and (UNITED STATES OF AMERICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $92.4M worth of Tacrolimus through 4,611 shipments from 299 suppliers to 127 countries, serving 727 buyers globally. Biocon Pharma Limited contributes $1.1M to this total, accounting for 0.5% of India's Tacrolimus exports. Biocon Pharma Limited ships Tacrolimus to 3 countries through 5 buyers.
Biocon Pharma Limited's average Tacrolimus shipment value is $50.0K per consignment, based on 22 shipments totaling $1.1M. The largest destination is MEXICO (49.9% of Biocon Pharma Limited's Tacrolimus exports).
Biocon Pharma Limited ranks #7 among 299 Indian Tacrolimus exporters with a 0.5% market share. The top 3 exporters are SANDOZ PRIVATE LIMITED ($36.9M), INTAS PHARMACEUTICALS LIMITED ($22.5M), ALKEM LABORATORIES LIMITED ($8.4M). Biocon Pharma Limited processed 22 shipments to 2 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TACROLIMUS CAPSULES 1MG 5 X10#S MEXICO | $350.0K | 7 |
| TACROLIMUS CAPSULES USP 1MG | $250.0K | 5 |
| TACROLIMUS CAPSULES USP 0.5MG | $200.0K | 4 |
| TACROLIMUS CAPSULES 1MG | $100.0K | 2 |
| TACROLIMUS CAPSULES USP 5MG | $98.2K | 2 |
| TACROLIMUS CAPSULES 1MG 5 X10#S | $50.0K | 1 |
| TACROLIMUS CAPSULES 5MG | $46.6K | 1 |
Biocon Pharma Limited exports 7 distinct Tacrolimus formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TACROLIMUS CAPSULES 1MG 5 X10#S MEXICO with 7 shipments worth $350.0K.
What Biocon Pharma Limited must comply with to export Tacrolimus to its top destination countries
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | DR REDDYS LABORATORIES LIMITED | $1.4M | 27 | 2 | $50.0K |
| 15 | DR.REDDY'S LABORATORIES LIMITED | $1.1M | 34 | 2 | $33.0K |
| 7 | BIOCON PHARMA LIMITED ★ | $1.1M | 22 | 2 | $50.0K |
| 3 | THE MADRAS PHARMACEUTICAL | $950.0K | 19 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 741 | 16.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 645 | 14.0% |
| DELHI AIR CARGO ACC (INDEL4) | 398 | 8.6% |
| NHAVA SHEVA SEA (INNSA1) | 358 | 7.8% |
| DELHI AIR | 320 | 6.9% |
| AHEMDABAD AIR ACC (INAMD4) | 175 | 3.8% |
| JNPT/ NHAVA SHEVA SEA | 169 | 3.7% |
| Bombay Air | 141 | 3.1% |
Biocon Pharma Limited also exports these immunosuppressants products. Each links to the detailed product page.
Biocon Pharma Limited exports 8 products worth $112.4M. Beyond Tacrolimus, top products include Calcium, Rosuvastatin, Atorvastatin, Esomeprazole, Magnesium. View the complete Biocon Pharma Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Tacrolimus — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Biocon Pharma Limited's Tacrolimus exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Biocon Pharma Limited
Full Company Profile →
8 products · $112.4M total trade · 4 categories
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| 4 |
| $50.0K |
| 11 | DR REDDY S LABORATORIES LIMITED | $800.0K | 16 | 2 | $50.0K |
Biocon Pharma Limited ranks #7 among 299 Indian Tacrolimus exporters. Average shipment value of $50.0K compared to the market average of $309.1K. The closest competitors by value are DR REDDYS LABORATORIES LIMITED and DR.REDDY'S LABORATORIES LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 127+ countries, 727+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Biocon Pharma Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tacrolimus. For current shipment-level data, contact TransData Nexus.